Molecular analysis of peroxisomal beta-oxidation enzymes in infants with Zellweger syndrome and Zellweger-like syndrome: further heterogeneity of the peroxisomal disorder. 1988

Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
Department of Pediatrics, Gifu University School of Medicine, Japan.

The biosynthesis of enzymes of peroxisomal beta-oxidation was investigated in an attempt to elucidate the mechanism of deficiencies of proteins of these enzymes in 3 infants with Zellweger syndrome and in a baby with Zellweger-like syndrome with clinical and biochemical findings consistent with Zellweger syndrome except that the peroxisomes were detected electronmicroscopically. Enzyme proteins of peroxisomal beta-oxidation, acyl-CoA oxidase, bifunctional protein and 3-ketoacyl-CoA thiolase were hardly detectable, in both syndromes. Total hepatic RNA extracted from the liver of one patient with each syndrome and three controls was translated in a rabbit reticulocyte lysate protein-synthesizing system in the presence of [35S]methionine. Translatable mRNAs for all of the peroxisomal beta-oxidation enzymes were detected in both patients at much the same levels seen in the controls. Pulse labelling and chase experiments of fibroblasts from the control revealed that the 72 kDa subunit of acyl-CoA oxidase was first synthesized, after which the 52 kDa and 21 kDa subunits were processed from the 72 kDa subunit. In the patient with Zellweger syndrome, little of the 52 kDa and 21 kDa subunits of acyl-CoA oxidase were synthesized. The mature form of peroxisomal 3-ketoacyl-CoA thiolase was also not processed from its precursor form, in this patient. We consider that Zellweger-like syndrome is a new variant form of a peroxisomal disorder in which biogenesis of peroxisomes is intact, while in contrast, the biogenesis of peroxisome is considered to be defective in those with Zellweger syndrome. Multiple defects of enzymes of beta-oxidation in Zellweger-like syndrome are assumed to be caused by a defect of transport or localization of these enzymes. Our molecular analyses indicate that the enzymes of peroxisomal beta-oxidation are synthesized in patients with Zellweger and Zellweger-like syndrome but that these enzymes are not processed normally and are degraded rapidly.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008830 Microbodies Electron-dense cytoplasmic particles bounded by a single membrane, such as PEROXISOMES; GLYOXYSOMES; and glycosomes. Glycosomes,Glycosome,Microbody
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000015 Abnormalities, Multiple Congenital abnormalities that affect more than one organ or body structure. Multiple Abnormalities
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated

Related Publications

Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
January 1986, Journal of inherited metabolic disease,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
April 1986, Clinica chimica acta; international journal of clinical chemistry,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
May 1989, Biochemical and biophysical research communications,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
February 1985, Biochemical and biophysical research communications,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
August 1986, Proceedings of the National Academy of Sciences of the United States of America,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
April 1999, Neurochemical research,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
January 2000, Cell biochemistry and biophysics,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
January 1990, Progress in clinical and biological research,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
May 2024, Pediatric blood & cancer,
Y Suzuki, and N Shimozawa, and T Orii, and N Igarashi, and N Kono, and T Hashimoto
January 1982, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!